1

Quanterix

#7839

Rank

$334.45M

Marketcap

US United States

Country

Quanterix
Leadership team

Dr. Masoud Toloue Ph.D. (Pres, CEO & Director)

Dr. David R. Walt Ph.D. (Co-Founder, Chairman of Scientific Advisory Board & Independent Director)

Mr. Michael A. Doyle (CFO & Treasurer)

Products/ Services
Biotechnology, Health Care, Health Diagnostics, Life Science, Pharmaceutical
Number of Employees
100 - 500
Headquarters
Billerica, Massachusetts, United States
Established
2007
Company Registration
SEC CIK number: 0001503274
Revenue
100M - 500M
Traded as
QTRX
Social Media
Overview
Location
Summary
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
History

Quanterix was founded by Jack Henkel, Aadil Kandhari, and Jun Tan in April 2007. The company's first product was the Simoa HD-1 Analyzer which combines EDC Chip technology and digital microfluidics to facilitate digital ELISA measurements. In December 2018 Quanterix secured a collaboration with the National Football League on its Concussion Testing Platform. Theplatform is aimed at understanding the effects of repetitive head trauma and improving protocols for detecting and treating head injuries.

Mission
We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In therapeutic areas that include neurology, oncology, cardiology, inflammation, and infectious disease, our revolutionary technology is helping researchers advance the science of precision health.
Vision
Quanterix's vision is to bring revolutionary healthcare advances to the point of care and create meaningful change in healthcare through innovation and collaboration.
Key Team

David Panzerella (VP of Sales)

Ms. Erica Bell (Chief People Officer)

Mr. Bruce J. Bal (VP of Operations, Service & Quality)

Mr. Daniel Pikora (Chief Operating Officer)

Ms. Mary Ellen Cortizas (VP of Laboratory Services & CRO)

Dr. Mark T. Roskey Ph.D. (Sr. VP of Strategic Partnerships)

Dr. David C. Duffy Ph.D. (Sr. VP of R&D and CTO)

Recognition and Awards
Quanterix won 3 awards in 2022 and 5 awards in 2021. In 2022, Quanterix won for Best Career Growth 2022, Best Places to Work in Boston 2022 and Best Company Outlook 2022. In 2021, Quanterix won for Best Company for Diversity 2021, Best Company for Women 2021, Best Company Culture 2021, Best Company Compensation and Best Company Happiness. Based on 1,112 ratings and 43 participants, employees at Quanterix are very satisfied with their work experience. The overall culture score, 88/100 or A+, incorporates employee ratings based on their feedback on the Professional Development, Team, Diversity and more.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Quanterix
Leadership team

Dr. Masoud Toloue Ph.D. (Pres, CEO & Director)

Dr. David R. Walt Ph.D. (Co-Founder, Chairman of Scientific Advisory Board & Independent Director)

Mr. Michael A. Doyle (CFO & Treasurer)

Products/ Services
Biotechnology, Health Care, Health Diagnostics, Life Science, Pharmaceutical
Number of Employees
100 - 500
Headquarters
Billerica, Massachusetts, United States
Established
2007
Company Registration
SEC CIK number: 0001503274
Revenue
100M - 500M
Traded as
QTRX
Social Media